FDA moves closer to sickle cell cure that uses gene editing

The Food and Drug Administration may be one step closer toward what could be the first approval of a drug that uses the groundbreaking gene-editing tool CRISPR. The drug, called exa-cel, treats sickle cell disease, an inherited blood disorder that affects an estimated 100,000 people in the U.S.,…

#bireeandemariam #vertex #crisprtherapeutics #fda #crispr #scotwolfe #lisalee #stateuniversity #josephwu #stephangrupp